Approval · Notice of Compliance 9002 · 2007
ANDROGEL: Notice of Compliance 9002
Issued August 30, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9002
- Date
- August 30, 2007
- Company
- Solvay Pharma Inc.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised product monograph, class labelling update
- Therapeutic class
- Androgenic hormone
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ANDROGEL | Not yet assigned | — |
| ANDROGEL (2.5G/PACKET) | Not yet assigned | — |
| ANDROGEL (5G/PACKET) | Not yet assigned | — |
Medicinal ingredients
- TESTOSTERONE 1 PER
- TESTOSTERONE 1 G per 100G